COVID-19 disrupting clinical trials, changing ‘essential’ cancer treatments – News – The University of Sydney

In light of physical distancing restrictions due to COVID-19, standard cancer procedures are being altered or delayed, including surveillance imaging; non-emergency surgical procedures; and clinical trials, Sydney lead and health sociologist, Professor Alex Broom said.
The suspension of clinical trials is especially detrimental for patients with rare cancers. For them, enrolling in a clinical trial for a promising new therapy may be the best option.
Many experimental labs where materials, incl…

Click here to view the original article.